Global Nanoparticle Drug Delivery Market: Dosage, Price and Clinical Pipeline Outlook to 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The report “Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2028” has been added to from ResearchAndMarkets.com offer.

Over the past few decades, there has been tremendous development in the field of delivery systems to deliver naturally based therapeutic agents or active compounds to the target location for the management of several diseases. Several drug delivery approaches have been used successfully in recent times, but there are still some challenges and advanced technology needs to be developed for successful drug delivery to target sites. In order to overcome these challenges, nanoparticle-based drug delivery systems are currently being investigated to facilitate the advanced drug delivery system.

Nanoparticle drug delivery is the emerging branch that uses nanotechnology in the prevention and treatment of various diseases using nanoscale materials, such as biocompatible nanoparticles and nanorobots for delivery of drugs to the target location. Several biopolymer nanoparticles can be used for drug delivery systems such as chitosan, xanthum gum, cellulose, liposomes, dendrimers and others. The liposome drug delivery approach is one of the most promising approaches and holds the maximum share of the global nanoparticle-based drug delivery market.

Companies in the liposome drug delivery market are increasingly focusing on drug delivery nanosystems involving major classes of antivirals and their transport across specific barriers at the cellular and intracellular levels. Thus, liposomes show promising potentials in ongoing research studies being conducted by healthcare companies for the treatment of coronavirus. Additionally, several pharmaceutical companies have also entered into collaboration or partnerships to boost this segment during the forecast period.

In addition to mitigating the high cost associated with nanoparticle-based drugs, research is also directed towards the development of cost-effective generic nanoparticle-based drugs. The generic nanoparticle drug has also seen a substantial increase in production because it is cheaper than the branded one and does not require extensive research and testing. Several pharmaceutical companies, including Mylan, Teva, Actavis, Lupine Laboratories, Sun Pharma and others, have launched their generic versions in the market, which have been widely accepted.

Global Nanoparticle Drug Delivery Market Report Highlights, Dosage, Price and Clinical Pipeline Outlook 2028:

  • Global Market Opportunity for Delivery of Nanoparticle Drugs >USD 300 Billion by 2028

  • Nanoparticle Drug Deliver Price and Dosage Overview by Therapeutics: Cancer, Anemia, Autoimmune Diseases, Neurological Disorders

  • Global Nanoparticle Drugs Market Regional Analysis: United States, Europe, China, Japan, India, Taiwan, South Korea, Canada

  • Nanoparticle Therapeutics Approved Drug Sales Snapshot: 15 Drugs

  • Nanoparticle Therapeutics Approved Drug Sales Forecast 2028: 15 Drugs

  • Global overview of the clinical pipeline of nanoparticle-based drugs by phase, company and indication: > 400 drugs

  • Nanoparticle Drug Delivery – Analysis of market trends and patent distribution

The global nanoparticle-based drug delivery market is expected to exceed US$300 billion by 2028. The market has high growth potential which is attributed to growing number of patients with chronic diseases, increasing research and development spending by pharmaceutical giants in the region with a strong clinical pipeline of nanoparticle-based drug delivery systems. Additionally, increase in disposable population leading to rising health and lifestyle awareness is also likely to propel the growth of the market. Furthermore, the availability of a wide range of generic drugs, which increases the accessibility among the general population, also propels the market growth over the forecast period.

The report provides a comprehensive analysis of commercially available nanomedicines, along with their price, dosage, generic availability, and sales analysis. Additionally, an in-depth analysis of the ongoing clinical trials in the report is also included in the report. Additionally, key players and their strategies are analyzed in-depth to provide competitive insights to the industry.

Main topics covered:

Nanoparticles – New Era of Drug Delivery Methodology

Need for nanoparticle drug delivery

Importance of Nanoparticle Drug Delivery in Cancer Treatment

  • Wide Application of Nanoparticles in Cancer Treatment

  • Mechanisms of internalization of nanoparticles in cancer cells for imaging and therapy

  • Role of nanoparticles in better cancer diagnosis

Nanoparticle-based drug delivery techniques

  • Nanocrystals

  • Liposomes

  • Dendrimers

  • Administration of micelle drugs

  • Polymer nanoparticles

  • Metal-based nanoparticles (gold, iron oxide)

  • Fullerenes and carbon nanotubes

  • Quantum dot delivery

Global Nanoparticle Drugs Market Overview

Regional Analysis of Global Nanoparticle Drugs Market

Global Nanoparticle Drugs Market by Indication

  • Oncology

  • Autoimmune diseases

  • iron deficiency

  • Neurological disorders

Cancer Nanoparticle Therapeutics – Price and Dosage Overview

  • Liposomal doxorubicin

  • Protein bound paclitaxel

  • Megace ES (improved stability)

  • Vyxeos (Cytarabine and Daunorubicin)

  • Markibo

  • Oncaspar (Pegaspargase)

  • Onivyde

  • Cynviloq

  • Hensify

  • Paccal

  • Mepact

  • Lipusu

  • Eligard

Anemia Nanoparticle Therapeutics – Price and Dosage Overview

  • Ferumoxytol (Feraheme)

  • Ferric Inject (Ferric Carboxymaltose)

  • Venofer

  • Ferrlecit

  • Powered

  • Mircera

Autoimmune Diseases Nanoparticle Therapeutics – Price and Dosage Overview

  • Copaxone (glatiramer)

  • Cimzia

  • Plegridy (Peginterferon beta-1a)

  • Krystexxa (Pegloticase)

  • Zilretta (triamcinolone acetonide)

Neurological Disorders Nanoparticle Therapeutics – Price and Dosage Overview

  • Onpattro (Patisiran)

  • Visudyne (verteporfin)

Analysis of prices and dosages of other commercially available nanoparticle therapeutics

  • Liposomal Amphotericin B

  • Rapamune

  • Emend (Aprepitant Nanocrystal)

  • Triglide – Nanocrystalline version of Tricor

  • Neulasta

  • Ritalin (Methylphenidate)

  • Renagel (Sevelamer)

  • Abelcet

  • Somavert (Pegvisomant)

  • Rebinyn/Refixia

  • Invega (paliperidone)

Nanoparticle Therapeutics Approved Drugs Worldwide – Sales Analysis and Forecast to 2028

  • Ambisome

  • Abraxane

  • Vyxeos

  • surpattro

  • Neulasta

  • Somavert

  • Zilretta

  • Copaxon

  • Mircera

  • Ironinject

  • Venofer

  • Onivyde

  • Cimzia

  • Plegridy

  • Krystexxa

Overview of Global Nanoparticle Clinical Trials

Global Nanoparticle Drugs Clinical Pipeline Overview by Phase, Company and Indication

Clinical overview of marketed nanoparticle drugs

Nanoparticle Drug Delivery Market Dynamics

Company Profiles:

  • AbbVie

  • Amgen

  • Alnylam Pharmaceuticals

  • Arrowhead Pharmaceuticals

  • BioGen

  • Bristol Myers Squibb

  • Clene Nanomedicine

  • Therapeutic Horizon

  • Merck

  • Nanobiotix

  • Nanospectra Biosciences

  • Novartis

  • Pfizer

  • Tandem-Nano

For more information about this report visit https://www.researchandmarkets.com/r/bk6en9

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

Comments are closed.